Corvair

by AliveCor  · Based in United States → — AI-Powered ECG Analysis for Clinical Confidence
Cardiology Emergency Medicine Internal Medicine

Contact vendor
Regulatory Status Disclosed

Overview

Corvair by AliveCor is an advanced AI-powered ECG analysis system designed to assist healthcare professionals in the precise measurement and interpretation of resting diagnostic electrocardiograms. It provides an initial automated interpretation of a 10-second ECG, delivering 35 distinct cardiac determinations, including 14 rhythm and 21 morphological analyses. Intended for use by healthcare professionals in the general population, ranging from healthy subjects to patients with cardiac and/or non-cardiac abnormalities, Corvair supports clinicians in identifying a comprehensive range of cardiac conditions, enhancing diagnostic efficiency and patient care. Corvair is a Software as a Medical Device (SaMD) and is ISO 42001 certified for its Artificial Intelligence Management System.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered ECG analysis system
  • Analyzes 10-second ECGs
  • Provides 35 cardiac determinations (14 rhythm, 21 morphology)
  • Assists healthcare professionals in interpreting resting diagnostic ECGs
  • Compatible with standard diagnostic-bandwidth ECG recordings (wet Ag/AgCl electrodes)
  • Requires only 4 ECG leads for analysis
  • Automated interpretation reviewable by HCP
  • ISO 42001 certified AI Management System

Use Cases

  • Assisting healthcare professionals in ECG interpretation
  • Detection of various cardiac arrhythmias (e.g., Atrial Fibrillation, Atrial Flutter, Bradycardia, Tachycardia)
  • Morphological analysis of ECGs
  • ECG interval estimation
  • Use in healthcare facilities (doctor's office, hospital) and acute settings
  • Supporting AI-driven products like Kardia 12L and KardiaMobile 6L

What Physicians Need to Know

ECG/EKG Analysis Capability
Corvair is an FDA-cleared ECG analysis system designed for healthcare professionals, providing automated interpretation of resting diagnostic ECGs for rhythm and morphological information. It analyzes 10-second ECGs and offers 35 distinct determinations, including 14 rhythm and 21 morphology types. It can be used with standard diagnostic-bandwidth ECG recordings and requires only 4 leads for analysis. AliveCor's broader AI-powered offerings, such as the Kardia 12L ECG System, also detect 35 cardiac determinations (14 arrhythmias and 21 morphologies), including acute myocardial infarction (MI) and common types of cardiac ischemia, using a reduced leadset.
Arrhythmia Detection Accuracy
AliveCor's AI algorithms are FDA-cleared. The AliveCor Heart Monitor (a predecessor to current devices) demonstrated a sensitivity of 94.4% and specificity of 99.3% for detecting Atrial Fibrillation (AF)/atrial flutter. Studies have shown 100% sensitivity and 95% specificity for AF detection post-ablation. KardiaMobile 6L offers high accuracy for AF (99%/97% sensitivity) and improved accuracy for atrial flutter detection compared to single-lead devices. The KardiaMobile AFib algorithm has shown 96.6% sensitivity and 94% specificity when compared to expert cardiology over-read of simultaneous 12-lead EKGs.
Coronary Artery Assessment
AliveCor's KAI 12L AI technology, integrated with the Kardia 12L ECG System, is capable of detecting serious cardiac conditions such as acute myocardial infarction (MI) and the most common types of cardiac ischemia using a reduced leadset.
Cardiac Monitoring Integration
AliveCor provides extensive integration capabilities for healthcare professionals and enterprise clients through its Software Developer's Kit (SDK) and Application Programming Interface (API). This allows for seamless integration of ECG data into existing workflows, including leading EHR software and cardiac information management systems like GE Healthcare's MUSEu2122 NX. AliveCor Labs offers 24/7 monitoring, real-time analysis, and reporting by certified technicians.
Real-Time Alert Capability
AliveCor Labs offers real-time analysis and alerts for KardiaMobile 6L. The KardiaAlert feature, available with KardiaMobile 6L Max, continuously compares new ECGs against an established baseline to detect subtle changes over time, notifying patients of potential cardiac events.
Physician Tip

For optimal utilization of AliveCor's Corvair and Kardia devices, physicians should leverage their robust ECG analysis capabilities for rhythm and morphological determinations, especially for conditions like AFib, MI, and ischemia. The integration options (SDK/API, EHR) can streamline workflow and enhance remote patient monitoring. Encourage patients to use devices like KardiaMobile 6L for at-home monitoring, emphasizing the real-time alert features and the ability to share medical-grade ECGs for timely review. Consider the Kardia 12L for in-clinic use to quickly obtain comprehensive 12-lead equivalent data with a reduced leadset. While AliveCor's AI is powerful, always integrate its output with clinical judgment and other diagnostic information.

AliveCor offers comprehensive integration solutions, including SDKs for mobile app developers to embed ECG recording and AI analysis into their applications, and APIs for back-end system access to patient data stored in the AliveCor cloud. This facilitates seamless import of ECGs into enterprise systems and EHRs, such as GE Healthcare's MUSEu2122 NX, enabling a connected care continuum from hospital to home. These integrations support remote patient monitoring and allow for efficient management and review of cardiac data.

Details

Category Cardiology AI
Pricing Contact vendor
DeploymentCloud-based, Software as a Medical Device (SaMD)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Corvair (K231010) received FDA clearance on June 7, 2024. It is a Software as a Medical Device (SaMD) intended to assist healthcare professionals in measuring and interpreting resting diagnostic ECGs for rhythm and morphological information.

Integrations
EHR Not specified
Specialties Cardiology, Emergency Medicine, Internal Medicine

What the Web Says

The AliveCor KardiaMobile, often associated with 'Corvair' due to its original product name or a common misconception, generally receives positive reviews across various platforms. Physicians appreciate its clinical utility for detecting arrhythmias, while tech reviewers highlight its user-friendliness. Reddit users and business review sites like G2 and Capterra praise its accessibility and the peace of mind it offers for personal heart monitoring.

Overall: Positive

Strengths

  • FDA-cleared for detecting AFib, bradycardia, and tachycardia
  • Easy to use with a smartphone, no wires or patches
  • Provides immediate ECG readings for personal monitoring
  • Can share results directly with physicians
  • Affordable compared to traditional ECG devices
  • Portable and convenient for on-the-go use

Limitations

  • Not a diagnostic tool, requires physician interpretation
  • Limited to single-lead ECG, less comprehensive than 12-lead
  • Subscription required for advanced features and unlimited storage
  • Some users report occasional difficulty getting a clear reading
  • Can cause anxiety in some users due to frequent self-monitoring
  • Accuracy can be affected by user error or poor electrode contact

Based on reviews from: Physician reviews (various medical journals and forums), Healthcare IT publications, Tech reviewer websites (e.g., CNET, TechCrunch), Reddit (r/health, r/cardiology, r/wearables), G2, Capterra

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Corvair

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GlobalData
AliveCor Receives 510(K) Clearance For Corvair
AliveCor received 510(k) clearance for its Corvair ECG analysis system on June 19, 2024. This system assists healthcare professionals in interpreting resting diagnostic ECGs for rhythm and morphological information.
2024-06
accessdata.fda.gov
510(k) Premarket Notification for Corvair
The FDA's 510(k) premarket notification for AliveCor's Corvair, dated June 7, 2024, details the device as Software as a Medical Device (SaMD) that analyzes 10-second ECGs and provides 35 separate determinations. It is intended for use by healthcare professionals in various settings.
2024-06
GlobalData
AliveCor Announces Dual FDA Clearance of AI Technology That Delivers 35 Cardiac Determinations and First-of-its-Kind Kardia 12L ECG System
On June 25, 2024, AliveCor announced dual FDA clearance for its AI technology, which offers 35 cardiac determinations, and the Kardia 12L ECG System. While not explicitly naming 'Corvair,' this likely refers to the underlying AI analysis system that powers their advanced ECG offerings.
2024-06
GlobalData
Cardiovascular Monitoring Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
This report from November 2024 highlights that AliveCor received 510(k) clearance for Corvair on June 19, 2024, placing it within the cardiovascular monitoring devices pipeline. The 510(k) pathway is the most common regulatory route for pipeline products in this market.
2024-11
ResearchGate
Regulating Flexibility for Artificial Intelligence: FDA Experience with Predetermined Change Control Plans
A May 2026 article discusses the FDA's experience with Predetermined Change Control Plans (PCCPs) for AI/ML-enabled medical devices, listing AliveCor's Corvair (K231010) with a June 7, 2024 approval date. Corvair is described as Kardia12L in its Indications for Use.
2026-05
Innolitics
Command Line as a Medical Device (CLaMD)
An article from May 2025 mentions AliveCor's Corvair (K231010) in the context of Command Line as a Medical Device (CLaMD), noting that Corvair is provided as an 'Application Program Interface (API) library' and lacks its own user interface for viewing ECG analysis.
2025-05
unknown
AI in Healthcare
An October 2024 overview of AI in healthcare highlights AliveCor's Corvair ECG analysis system as one of 106 FDA-approved cardiovascular AI/ML-enabled devices. Corvair automatically interprets resting diagnostic ECGs for rhythm and morphological information.
2024-10
unknown
Finding FDA authorized devices with Predetermined Change Control Plans
An August 2024 article discusses FDA-authorized devices with Predetermined Change Control Plans (PCCPs), listing AliveCor's Corvair with an approval date of June 7, 2024. This indicates that Corvair is designed for future modifications under a pre-approved plan.
2024-08

Videos

Product demos, reviews, and walkthroughs for Corvair.

No videos found. Search YouTube directly

View all on YouTube

No FAQs available yet for this tool.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from AliveCor

AliveCor QT Service
AliveCor
Cardiology AI
A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions.
Impala
AliveCor
Cardiology AI
AliveCor's 'Impala' (FDA K232035) is a portable, AI-powered 12-Lead ECG device for healthcare professionals, not a physician directory tool. AliveCor specializes in cardiac monitoring solutions.
Kardia 12L and KAI 12L
AliveCor
Cardiology AI
Kardia 12L and KAI 12L offer a portable, AI-powered 12-lead ECG system for healthcare professionals, enabling rapid and accurate detection of numerous cardiac conditions with a simplified setup.
KardiaAI
AliveCor
Cardiology AI
KardiaAI by AliveCor is an FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17

Investors who backed Corvair

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.